Bio-waiver of Sapro­pterin dihydrochloride powder for oral solution [Dissolution / BCS / IVIVC]

posted by AB661 – India, 2019-11-22 16:49 (467 d 07:11 ago) – Posting: # 20861
Views: 2,450

Dear All,

We are developing Sapropterin dihydrochloride powder for oral solution,

We are going to file BCS based Bio-waiver approach using solubility, dissolution & composition similarity.

But for permeability study there is no literature support for human absolute bioavailability study or in-vitro permeability study of Sapropterin dihydrochloride. Whether USFDA accept our proposal without permeability study data ?

With regards
AB


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

Activity
 Admin contact
21,361 posts in 4,461 threads, 1,493 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Thursday 00:01 UTC (Europe/Vienna)

Being really good at C++ is like being really good
at using rocks to sharpen sticks.    Thant Tessman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5